Berman Mc Aleer LLC Immuneering Corp Transaction History
Berman Mc Aleer LLC
- $715 Billion
- Q3 2025
A detailed history of Berman Mc Aleer LLC transactions in Immuneering Corp stock. As of the latest transaction made, Berman Mc Aleer LLC holds 25,000 shares of IMRX stock, worth $160,500. This represents 0.02% of its overall portfolio holdings.
Number of Shares
25,000Holding current value
$160,500% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding IMRX
# of Institutions
46Shares Held
4.14MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.06MShares$6.79 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0574KShares$3.68 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$3.42 Million0.0% of portfolio
-
Iridian Asset Management LLC275KShares$1.77 Million0.75% of portfolio
-
Southport Management, L.L.C. Wilson, WY245KShares$1.57 Million4.03% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $169M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...